GWG Holdings” Insurtech Subsidiary, Life Epigenetics, Retains Insurance Technology and Testing Executive Michael P. Curran as Senior Advisor

Life Epigenetics holds the exclusive license for lifespan-predictive technology developed at the University of California, Los Angeles (UCLA) for the life insurance industry.

Curran most recently served as President and CEO of Force Diagnostics, Inc., a leading international provider of FDA-approved rapid tests and infrastructure software for the insurance industry and other large vertical markets. Curran has more than 25 years of proven experience as a senior operating executive, corporate strategist and venture capitalist inside the financial services industry, with a specific focus on insurance.

As President of Quantitative Data Solutions (QDS), he directed the aggregation, development and commercialization of the use of prescription transaction history records and predictive analytics to quantify the use of those records in the Life Insurance underwriting process. QDS then built an automated underwriting engine, Velogica, that was subsequently purchased, with the data assets and imbedded models, by TransamericaRe/NYSE:AEG.

Attachments:

Attachments: